We are live on ! Find out more

11 hedge funds and large institutions have $1.86M invested in PAVmed in 2018 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,221% more capital invested

Capital invested by funds: $141K → $1.86M (+$1.72M)

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

83% more funds holding

Funds holding: 611 (+5)

0.01% more ownership

Funds ownership: 0%0.01% (+0.01%)

Holders
11
Holders Change
+5
Holders Change %
+83.33%
% of All Funds
0.25%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
1
Reduced
Closed
2
Calls
Puts
Net Calls
Net Calls Change

PAVM Hedge Fund Activity: Q1 2018 in Review

11 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q1 2018, worth a combined $1.86M — up 1,221% from $141K a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new PAVM positions and 2 closed out — a net gain of 5 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $1.73M. The largest seller was Millennium Management, exiting entirely with an estimated $47K sold.

  • 11 institutional investors held PAVmed (PAVM) as of Q1 2018, up from 6 in Q4 2017.
  • Funds reported $1.86M of PAVmed stock for Q1 2018, up 1,221% quarter-over-quarter.
  • 7 funds opened new PAVmed positions in Q1 2018 and 2 closed out, a net change of +5 holders.
  • The largest PAVmed buyer in Q1 2018 was Sabby Management, an estimated $1.73M added.
  • The largest PAVmed seller in Q1 2018 was Millennium Management, an estimated $47K sold.

Based on aggregated 13F filings for Q1 2018.